Immediate vs Delayed Catheterization and Angioplasty Following Thrombolytic Therapy for Acute Myocardial Infarction: TIMI II A Results

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 19, 1988, Pages 2849-2858

 

^a TIMI Research Group ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; BLOOD CLOT LYSIS; FATALITY; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEMORRHAGE; HEPARIN; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; STROKE VOLUME; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0023771557     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410190097031     Document Type: Article

References (18)

1. Monthly Vital Statistics Report. National Center for Health Statistics, 1987, vol 35.
2. 1986 Summary: National Hospital Discharge Survey. National Center for Health Statistics, 1987.
3. DeWood MA, Spores J, Notske R, et al.: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
4. Rentrop PK: Thrombolytic therapy in patients with acute myocardial infarction. Circulation 1985;71:627-631.
5. Simoons ML, van der Brand M, de Zwabb C, et al.: Improved survival after early thrombolysis in acute myocardial infarction. Lancet 1985;2:578-581.
6. GISSI: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
7. AIMS Trial Study Group: Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial. Lancet 1988;1:546-549.
8. Chesebro JH, Knatterud GL, Roberts R, et al.: Thrombolysis in Myocardial Infarction (TIMI) Trial Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase—clinical findings through hospital discharge. Circulation 1987;76:142-154.
9. Williams DO, Borer J, Braunwald E, et al.: Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: A report from the NHLBI Thrombolysis in Myocardial Infarction Trial. Circulation 1986; 73:338-346.
10. Passamani E, HodgesM, Herman M, et al.:The Thrombolysis in Myocardial Infarction (TIMI) Phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1987;10:51B-64B.
11. TIMI Operations Committee, Braunwald E, Knatterud GL, et al.: Announcement of protocol change in Thrombolysis in Myocardial Infarction Trial. J Am Coll Cardiol 1987;9:467.
12. TIMI Operations Committee, Braunwald E, Knatterud GL, et al.: Update from the Thrombolysis in Myocardial Infarction (TIMI) Trial. J Am Coll Cardiol 1987;10:970.
13. Brown BG, Bolson EL, Frimer M, et al.: Quantitative coronary arteriography: Estimation of dimensions, hemodynamic resistance and atheroma mass of coronary artery lesions using the arteriogram and digital computation. Circulation 1977;55:329.
14. Snedecor GW, Cochran WG: Statistical Methods. Ames, The Iowa State University Press, 1967, pp 100-106,128-130.
15. Peto R, Pike MC, Armitage P, et al.: Design and analysis of randomized clinical trials requiring prolonged observations in each patient: I. Introduction and design. Br J Cancer 1976;34:585-612.
16. Topol EJ, Califf RM, George BS, et al.: A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-588.
17. Bovill E: Dose response relationship of rt-PA infusion to induction of systemic fibrin(ogen)olysis in the Thrombolysis in Myocardial Infarction (TIMI) Trial. Blood 1987;70(suppl 1):367a.
18. Simoons ML, Betriu A, Col J, et al.: Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No additional benefit from immediate coronary angioplasty. Lancet 1988;1:197-203.